Market Reports Online

2017 Global Prefilled Syringes Industry Opportunities and Trends

MarketReportsOnline.com adds “Global Prefilled Syringes Market: Trends & Opportunities (2012-2017)” report to its research store.

 

Dallas, TX -- (ReleaseWire) -- 04/16/2014 -- Pre-Filled Syringes market is growing at a very rapid pace owing to its usability, convenience, accuracy of dose and shortest possible time for injecting medicine. Globally, as the pharmaceutical industry is witnessing transition from administration of injections in clinician settings to home care settings, medical device manufacturers are also shifting their focus to the development of user friendly and patient compliant devices. Prefilled syringes are a result of this transition.

Demand for prefilled syringes is also driven by two other factors - mandatory protection of healthcare workers from needle stick injuries in the US and European countries and also reduction in drug overfills. This mandatory requirement in major healthcare markets has resulted in the overall increase in consumption of prefilled syringes in place of standard syringes before each dose is administered.

Purchase a copy of this report @ http://www.marketreportsonline.com/contacts/purchase.php?name=295900.

The prefilled syringes market is one of the fastest growing and profitable segments of global injectables market. Ease and accuracy associated with use of prefilled syringes has made pre filled syringes a fast-growing alternative to vials for many parenteral drugs such as vaccines, anticoagulants and therapeutic proteins.

The report titled "Global Prefilled Syringes Market: Trends & Opportunities (2012-2017)" provides an in-depth analysis of the global prefilled syringes market with major focus on biggest healthcare markets of U.S and Europe. It also assesses the key opportunities in the market and also outlines the factors that are and will be driving the growth of the industry. Further, key players of the industry like Becton Dickinson, Unilife, Baxter, Covedian and Thermo Fisher have been profiled and growth of the industry has been predicted taking into consideration the previous growth patterns, the growth drivers and the current and future trends.

Major points from Table of Contents (http://www.marketreportsonline.com/295900-toc.html ) are listed below:

1. Executive Summary
2. Global Injectable Drug Market: Overview
3. Global Pre-Filled Syringes Market: Overview
4. Prefilled Syringes: Advantages
5. Global Pre Filled Syringe Market
6. The U.S.: Prefilled Syringes Market
7. Europe: Prefilled Syringes Market
8. Global Pre Filled Syringes: Technological Analysis
9. Global Pre Filled Syringes Market
10. Global Pre Filled Syringes Market Trends

11. Company Profiles
11.1 Unilife Corporation
11.2 Becton, Dickinson and Company
11.3 Baxter International, Inc.
11.4 Covidien Plc
11.5 Thermo Fisher Scientific Inc.

12. Recommendations
13. About Us
14. Disclaimer
List of Figures
List of Tables

Related Reports on Pharmaceuticals Market:

US Orphan Drug Market Outlook 2018 (http://www.marketreportsonline.com/311704.html ) In the largest market for orphan drugs, USA, there was a shortage of adequate therapies for treating many rare diseases. These therapies were not developed as companies did not expect these drugs to be highly profitable. Hence there was a lack of interest and thus investment on the part of pharma companies in the USA. Therefore, the FDA introduced incentives for developing such drugs. This step taken by the FDA was successful in creating a thriving market for orphan drugs.

US Cancer Vaccine Market Outlook 2018 (http://www.marketreportsonline.com/311262.html ) Cancer vaccines are a viable option for treating many types of cancers which in the present day do not have effective treatments. Therapeutic cancer vaccines and Prophylactic cancer vaccines are the two broad segments into which the cancer vaccines market is categorized.

Singapore Clinical Trial Market Analysis (http://www.marketreportsonline.com/323344.html ) Singapore has off late come to become the nucleus of clinical research activities in the Asia-Pacific region. The country is a natural hub for manufacturers and clinicians. It also possesses one of the best healthcare infrastructure networks in the entire region. Singapore is the third largest market in Asia for conducting clinical trials.

Contact sales@marketreportsonline.com for further information/ details.